🇯🇵 Eliglustat GZ385660 in Japan

Eliglustat GZ385660 (Eliglustat GZ385660) regulatory status in Japan.

Marketing authorisation

Eliglustat GZ385660 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Eliglustat GZ385660 approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for Eliglustat GZ385660 in Japan?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.